MGMT, GATA6, CD81, DR4, and CASP8 gene promoter methylation in glioblastoma.

Skiriute D, Vaitkiene P, Saferis V, Asmoniene V, Skauminas K, Deltuva VP, Tamasauskas A

Open source

DOI
10.1186/1471-2407-12-218
Published
2012 Jun 6
Container
BMC cancer
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/1471-2407-12-218,
  title = {MGMT, GATA6, CD81, DR4, and CASP8 gene promoter methylation in glioblastoma.},
  author = {Skiriute D and Vaitkiene P and Saferis V and Asmoniene V and Skauminas K and Deltuva VP and Tamasauskas A},
  year = {2012},
  journal = {BMC cancer},
  doi = {10.1186/1471-2407-12-218},
  url = {https://doi.org/10.1186/1471-2407-12-218}
}

RIS

TY  - JOUR
TI  - MGMT, GATA6, CD81, DR4, and CASP8 gene promoter methylation in glioblastoma.
AU  - Skiriute D
AU  - Vaitkiene P
AU  - Saferis V
AU  - Asmoniene V
AU  - Skauminas K
AU  - Deltuva VP
AU  - Tamasauskas A
PY  - 2012
JO  - BMC cancer
DO  - 10.1186/1471-2407-12-218
UR  - https://doi.org/10.1186/1471-2407-12-218
ER  - 

APA

D, S., P, V., V, S., V, A., K, S., VP, D., & A, T. (2012). MGMT, GATA6, CD81, DR4, and CASP8 gene promoter methylation in glioblastoma.. BMC cancer. https://doi.org/10.1186/1471-2407-12-218

Source records